Review articleTransdermal buprenorphine (cas 136232-82-1) patch: Potential for role in management of opioid dependence
-
Add time:09/04/2019 Source:sciencedirect.com
Despite proven clinical utility, use of sublinugual buprenorphine (cas 136232-82-1) is fraught with issues of potential diversion among patients with opioid dependence. Transdermal buprenorphine patches provide an alternative delivery model that can be utilized to reduce such diversion. This narrative review discusses the transdermal buprenorphine formulations, and its pharmacology, drug interaction and tolerability profile. The studies utilizing buprenorphine transdermal patches in the treatment of opioid dependence are examined, while the potential of using such patches for maintenance treatment of opioid dependence is examined.
We also recommend Trading Suppliers and Manufacturers of buprenorphine (cas 136232-82-1). Pls Click Website Link as below: cas 136232-82-1 suppliers
Prev:Research Paper“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine (cas 136232-82-1) use in a time of treatment expansion
Next:A comparison of buprenorphine (cas 136232-82-1) and psychosocial treatment outcomes in psychosocial and medical settings) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Short CommunicationPerceived need and availability of psychosocial interventions across buprenorphine (cas 136232-82-1) prescriber specialties09/07/2019
- Epidemiology of severe buprenorphine (cas 136232-82-1) exposures reported to the U.S. Poison Centers09/06/2019
- A comparison of buprenorphine (cas 136232-82-1) and psychosocial treatment outcomes in psychosocial and medical settings09/05/2019
- Research Paper“They're making it so hard for people to get help:” Motivations for non-prescribed buprenorphine (cas 136232-82-1) use in a time of treatment expansion09/03/2019
- Evaluation of an emergency department buprenorphine (cas 136232-82-1) induction and medication-assisted treatment referral program09/02/2019
- Full length articleUnderstanding the use of diverted buprenorphine (cas 136232-82-1)09/01/2019
- Effects of ascending buprenorphine (cas 136232-82-1) doses on measures of experimental pain: A pilot study08/31/2019
- buprenorphine (cas 136232-82-1) in the United States: Motives for abuse, misuse, and diversion08/30/2019
- Full length articleMaternal buprenorphine (cas 136232-82-1) treatment during pregnancy and maternal physiology08/29/2019
-
Health and Chemical more >
-
Related Products